The UK Innovation & Science Seed Fund is a public/private partnership fund that provides venture capital to kick-start innovative science and technology companies stemming from the UK's research base. It aims to bridge the funding gap between research and later-stage venture capital investment.

UK Innovation & Science Seed Fund

The UK Innovation & Science Seed Fund (formerly known as The Rainbow Seed Fund) is an early-stage venture capital fund dedicated to kick-starting promising technology companies developed at some of the UK’s largest publicly-funded research facilities.


Today UK Research and Innovation have announced additional investment into the UK Innovation & Science Seed Fund from UKRI and the UK Ministry of Defence, bringing total funding over £100 million for the first time.

Since we launched in 2002, we have been providing crucial support to emerging innovators, with a remarkable impact on the UK economy. From investments totalling £30 million, we've attracted a return of £25 of private investment for every £1 of public money. Companies supported have created over 1,100 high-quality jobs across the UK and an impressive range of real-world impacts.

Organisations we are proud to have worked with include 👇🏽 

Tokamak Energy - working on transforming the delivery of fusion energy to the National Grid by the 2030s.
 
SOLASTA Bio - creating world-first green insecticides using tech developed at the University of Glasgow
 
iFAST Diagnostics - using rapid diagnostic tech to identify antibiotic resistance ten times faster than the current gold standard
 
Crescendo Biologics Limited - a spinout from The The Babraham Institute trialling novel therapeutics that use the immune system to treat and manage cancer
 
Luffy AI - delivering the next generation in adaptive intelligence for robotics and industrial control

Science Minister George Freeman MP comments on the investment: "Innovation is about the seed of an idea being brought to life and I am proud that public investment is continuing to kickstart vital scientific discoveries, including new cancer treatments and technology to identify antimicrobial resistance, that can transform our society’s health and prosperity.

"This funding, reaching over £100 million with today’s investment, has so far supported more than a thousand high-quality jobs across the UK and secured more than £700 million of further private investment, in turn levelling up our country and boosting our economy." 

Our very own Investment Director, Andrew Muir adds, "The continuous support and investments from our public sector partners solidify the Fund’s position in the early-stage ecosystem for ground-breaking ideas. We are thrilled to continue enabling the growth of innovative ventures that will shape the future of industries and benefit the UK economy." 

If you are looking for early stage investment within the #BioEngineering, #Defence #Security #cybersecurity #Fusion #energy and #knowledge industries - come and talk to us 👉🏽 https://lnkd.in/ezDDwgid  

More on today's announcement 👇🏽
https://lnkd.in/eBscdJ5F   
 

Join UKI2S' Investment Director, Alexander Leigh 🎙🎥 , next Tuesday 6th Feb at Access to Finance 2024 as part of a panel discussing 'Getting your Cutting-Edge Idea off the Ground – The Ins and Outs of Pre-Seed'

Access to Finance 2024 is hosted by THE SCIENCE AND TECHNOLOGY FACILITIES COUNCIL in collab with Oxfordshire Greentech and Cambridge Cleantech bringing together experts and investors helping you find out what finance and support is available for your business.

👇
https://lnkd.in/eMxSMT9Q

#Investment #VentureCapital #Funding Future Planet Capital

Exciting news!

Thrilled to welcome Joyeeta Das to the UKI2S family as our newest Advisory Board Member.

With a global career spanning the UK, Germany, India, and the US, Joyeeta brings invaluable expertise in tech and data science. 🌟

CEO & Co-Founder of SamudraOceans, champion for women in innovation, and a force for positive change…Welcome aboard, Joyeeta!

#UKI2S #Investment #VentureCapital Future Planet Capital

UKI2S's Hassan Mahmudul attended today's BioSeed 2024 - a fast-paced pitching event for the most innovative organisations and investors in the life sciences industry. 🌱

Fantastic to see our some of our portfolio companies on stage:
👉 Vineeta Tripathi, CEO of Vitarka Therapeutics
👉 Dr Charlotte Henderson, CEO of RevoNA Bio

Thanks for having us #BioSeed2024! Images from the day 👇

#Investment #VentureCapital OBN (UK) Ltd Future Planet Capital Alexander Leigh 🎙🎥Andrew Muir

The UK government is planning to invest over £20 billion per annum on research and development.

But different funding mechanisms are needed to translate that science into impact.

That’s where UKI2S, a fund managed for the Government, comes in; we inject commercial discipline into the development and expansion of science, to push it towards successful, impactful commercialisation.

We want to build on what the British have already invested, by attracting private sector capital and foreign direct investment from sovereign funds.

Could 2024 be ‘The Year of Ambitious Growth?’ Douglas Hansen-Luke from Future Planet Capital  has shared his key investment predictions with us 👇

https://lnkd.in/evJSN53e

#Investment #VentureCapital

msh id	UK:CO:UKINNOVATIONSCIENCESEEDFUND
symbol	-
name	UK Innovation & Science Seed Fund
homepage url	https://ukinnovationscienceseedfund.co.uk
country	GB
sector	Financial Services & Finance
industry	Venture Capital
market	PRIVATE
employee count	14
crunchbase url	https://www.crunchbase.com/organization/innovate-u-k-
linkedin url	https://www.linkedin.com/company/uki2s
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

UK:CO:UKINNOVATIONSCIENCESEEDFUND

UK Innovation & Science Seed Fund

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-